首页> 外国专利> Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells

Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells

机译:通过将人间充质干细胞与cd34 +细胞共同培养来生产巨核细胞

摘要

The present invention is directed to hematopoietic progenitor cells isolated from a tissue specimen, such as marrow cells or peripheral blood, and to the method of co-culturing isolated hematopoietic progenitor cells with human mesenchymal stem cells to induce megakaryocyte differentiation and platelet production. In addition, hematopoietic stem cells can be genetically engineered to carry genes of interest particularly for the expression of physiologically active proteins. In the presence of mesenchymal stem cells, the transduced cells carry the new genetic material and express gene products that can be used to modulate blood disorders.
机译:本发明涉及从组织标本中分离的造血祖细胞,例如骨髓细胞或外周血,以及将分离的造血祖细胞与人间充质干细胞共培养以诱导巨核细胞分化和血小板产生的方法。另外,可以对造血干细胞进行基因工程改造,使其携带感兴趣的基因,尤其是用于表达生理活性蛋白的基因。在存在间充质干细胞的情况下,转导的细胞携带新的遗传物质并表达可用于调节血液疾病的基因产物。

著录项

  • 公开/公告号AU4094099A

    专利类型

  • 公开/公告日1999-12-13

    原文格式PDF

  • 申请/专利权人 OSIRIS THERAPEUTICS INC.;

    申请/专利号AU19990040940

  • 发明设计人 PANKAJ QASBA;MARK A. THIEDE;

    申请日1999-05-21

  • 分类号C12N5/08;C12N5/10;

  • 国家 AU

  • 入库时间 2022-08-22 01:51:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号